Tenax Therapeutics Inc (TENX)

[elviscobain2000]

Sure it's a new drug, new to the company. And actually we should be thanking Abbott, they PAID for Phase 1 & Phase II trials. Thanks Abbott! Unfortunately THEY were testing it for the WRONG indication. Sometimes big companies go down the wrong path. So after spending all that time and money to make it a Phase III candidate they gave it back to Orion. John Kelley being the astute CEO that he is said hey, this drug would work great for LCOS! So far he's proven that with a round of $52 million from institutions and retail investors, so the drug is not financially unfeasible. Considering DUKE university has signed on, done meta studies, and will oversee 50 hospitals is no small task. Add to the mix the lower risk profile of a typical drug because there is meta data available since it's been in use in over 50 different countries around the world and you truly have a unique investment opportunity.